Biologics for chronic rhinosinusitis with nasal polyps

The Journal of Allergy and Clinical Immunology
Claus BachertOlga Krysko

Abstract

With the increasing recognition of the role of type 2 immune responses in chronic rhinosinusitis, its severity, recurrence, and comorbidities, several biologics targeting IL-4, IL-5, and IL-13 as well as IgE have been administered in small proof-of-concept studies. Recently, the first phase 3 trials have been reported with dupilumab, an IL-4 receptor antagonist, demonstrating a significant and clinically relevant reduction of the disease burden from polyp size and sinus involvement to symptoms and smell; these changes consecutively led to an important increase in quality of life. Finally, the biologic versus placebo treatment reduced the need for systemic glucocorticosteroids and sinus surgery significantly and clinically meaningfully. Dupilumab today is registered for the treatment of chronic rhinosinusitis with nasal polyps in Europe and the United States. Within a year, 2 further phase 3 trials with omalizumab and mepolizumab will be reported. With this development, without any doubt, a new era for the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps has begun. Questions on the indication of the biologics, the selection of patients, and finally criteria for monitoring the efficacy in individual patie...Continue Reading

References

Aug 9, 1973·The New England Journal of Medicine·M KalinerK F Austen
Jan 1, 1970·International Archives of Allergy and Applied Immunology·R DonovanJ F Soothill
Apr 1, 1997·American Journal of Respiratory and Critical Care Medicine·Z YasruelQ Hamid
Jun 1, 1997·The Journal of Allergy and Clinical Immunology·C BachertC Rudack
Aug 3, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S Romagnani
Apr 11, 2001·The Journal of Allergy and Clinical Immunology·C BachertP van Cauwenberge
Oct 9, 2001·The Journal of Allergy and Clinical Immunology·S M PopeM E Rothenberg
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Patrick T Flood-PageDouglas S Robinson
Mar 9, 2005·The Journal of Allergy and Clinical Immunology·Stephen HolgateColin Reisner
Oct 13, 2006·The Journal of Allergy and Clinical Immunology·Allison-Lynn AndrewsDonna E Davies
Nov 8, 2006·The Journal of Allergy and Clinical Immunology·Philippe GevaertClaus Bachert
Aug 12, 2008·Current Molecular Medicine·Douglas A Kuperman, Robert P Schleimer
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·April E PriceRichard M Locksley
Sep 3, 2010·The Journal of Allergy and Clinical Immunology·Claus BachertKristel Van Steen
Nov 27, 2010·Thorax·María del Carmen VenneraManuel Bernal-Sprekelsen
Aug 27, 2011·The Journal of Allergy and Clinical Immunology·Koen Van CrombruggenClaus Bachert
Oct 1, 2011·The Journal of Allergy and Clinical Immunology·Philippe GevaertClaus Bachert
Nov 15, 2011·The Journal of Allergy and Clinical Immunology·Jillian L BarlowAndrew N J McKenzie
Dec 6, 2011·Nature Immunology·Hong-Erh LiangRichard M Locksley
May 29, 2012·The Journal of Allergy and Clinical Immunology·Deepti R NagarkarAtsushi Kato
Jul 31, 2012·The Journal of Allergy and Clinical Immunology·Michael B SoykaCezmi A Akdis
Oct 2, 2012·The Journal of Allergy and Clinical Immunology·Philippe GevaertClaus Bachert
Mar 12, 2013·The Journal of Allergy and Clinical Immunology·Kathryn E HulseRobert P Schleimer
Apr 2, 2013·The Journal of Allergy and Clinical Immunology·Atsushi KatoRobert P Schleimer
May 22, 2013·The Journal of Allergy and Clinical Immunology·Deepti R NagarkarAtsushi Kato
Jun 29, 2013·American Journal of Respiratory and Critical Care Medicine·Joanne L ShawAmber Luong
Sep 6, 2013·Clinical and Translational Allergy·Marcia A ChanLanny J Rosenwasser
Feb 28, 2014·International Forum of Allergy & Rhinology·Gina ParisAndrew P Lane
Mar 15, 2014·Nature Reviews. Immunology·Lawren C Wu, Ali A Zarrin
Jun 17, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S BabaT Yamasoba
Aug 7, 2014·The World Allergy Organization Journal·Stephen T Holgate
Sep 10, 2014·The New England Journal of Medicine·Hector G OrtegaUNKNOWN MENSA Investigators

❮ Previous
Next ❯

Citations

May 10, 2020·Expert Opinion on Biological Therapy·Bettina Wedi
Aug 28, 2020·Frontiers in Pharmacology·Seong-Dae WooHae-Sim Park
Sep 26, 2020·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Yin YaoZheng Liu
Nov 24, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Claus BachertTanya M Laidlaw
Jan 20, 2021·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Carlo CavaliereMarco Segatto
Mar 7, 2021·The Journal of Allergy and Clinical Immunology·Di WuLuo Zhang
Jan 13, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Claus Bachert
Mar 25, 2021·The Journal of Allergy and Clinical Immunology·Claus BachertWilliam W Busse
Dec 29, 2020·European Annals of Otorhinolaryngology, Head and Neck Diseases·S BartierE Béquignon
Apr 26, 2021·The Journal of Allergy and Clinical Immunology·Tim DelemarreClaus Bachert
Apr 20, 2021·The Lancet. Respiratory Medicine·Joseph K HanUNKNOWN SYNAPSE study investigators
Jun 3, 2021·International Forum of Allergy & Rhinology·Matthew A TylerAmber U Luong
Jun 1, 2021·Expert Review of Respiratory Medicine·Maria De FilippoGian Luigi Marseglia
Jun 13, 2021·International Journal of Pediatric Otorhinolaryngology·Zohaib SiddiquiAnastasia Rachmanidou
Jul 4, 2021·Otolaryngologic Clinics of North America·Uma S RamaswamyStella E Lee
Sep 9, 2021·Photodermatology, Photoimmunology & Photomedicine·Jin-Chun Chen, Cui-Hong Lian
Oct 2, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Hannah WangbergAndrew A White
Sep 22, 2021·Current Opinion in Otolaryngology & Head and Neck Surgery·Masanobu SuzukiAlkis James Psaltis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Claire Hopkins
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
Long WanYonghua Cui
The Journal of Allergy and Clinical Immunology
Robert C Kern
© 2021 Meta ULC. All rights reserved